| Autor: |
Ahuja KR; Eastern Virginia Medical School, Norfolk, Virginia, USA. Electronic address: ahujak@evms.edu., Lio PA; Northwestern University, Department of Dermatology, Chicago, Illinois, USA. |
| Abstrakt: |
Competing Interests: Declaration of competing interest Dr Lio reports research grants/funding from AbbVie, AOBiome, and Regeneron/Sanofi Genzyme; is on the speaker's bureau for AbbVie, Eli Lilly, Galderma, Hyphens, Incyte, LEO Pharma, L'Oreal, MyOr Diagnostics, ParentMD, Pfizer, and Regeneron/Sanofi Genzyme; reports consulting/advisory boards for AbbVie, Almirall, Amyris, AOBiome, Arbonne, ASLAN Pharmaceuticals, Burt's Bees, Castle Biosciences, Codex Labs, Concerto Biosciences (stock options), Dermavant, Eli Lilly, Exeltis, Galderma, IntraDerm, Johnson & Johnson, LEO Pharma, L'Oreal, Menlo Therapeutics, Micreos (stock options), Pfizer, Pierre-Fabre, Regeneron/Sanofi Genzyme, Theraplex, and Unilever; has a patent pending for a Theraplex product with royalties paid; and serves as a board member and scientific advisory committee member of the National Eczema Association. KA reports no conflict of interest. |
Full Text from ScienceDirect